What is brain death and why is Supreme Court reviewing the way it’s certified?

The legal framework for brain death and organ donation in India is governed by the Transplantation of Human Organs and Tissues Act, 1994 (THOTA). This act provides a statutory definition of brain stem death and established the legal basis for deceased organ donation. Under THOTA, brain death certification requires a stringent protocol involving a board of four medical experts, including a neurologist or neurosurgeon, who must independently certify the cessation of brain stem function twice, with a 6-hour interval for adults (as per THOTA Rules 2014), though the article specifically mentions a 12-hour protocol being reviewed. The Supreme Court of India's intervention highlights the ongoing tension between medical practice and legal certainty. The court is exercising its power of judicial review to ensure that the fundamental Article 21 (Right to Life) is not compromised by potentially subjective medical assessments. The debate centers on the reliability of the apnea test, a clinical evaluation to check for spontaneous breathing, versus the need for objective, instrumental tests like Electroencephalogram (EEG) or Angiography. The court must balance the need for rigorous legal safeguards against the practical realities of healthcare access in India.

From a public policy perspective, this issue underscores the challenges in regulating complex medical procedures across a diverse healthcare system. The apex body, National Organ and Tissue Transplant Organisation (NOTTO), sets the national guidelines for brain death certification. Currently, NOTTO guidelines mandate clinical tests (like the apnea test, pupil reaction, and gag reflex) but do not explicitly require instrumental tests like EEG. The policy dilemma lies in the fact that while instrumental tests offer definitive proof of brain death (showing lack of electrical activity or blood flow), mandating them could severely restrict the number of hospitals capable of declaring brain death. Tertiary care centers often have these facilities, but many smaller hospitals and trauma centers do not. If these tests become mandatory, organ harvesting from deceased donors could plummet, exacerbating the critical shortage of organs in India (currently at a dismal 0.77 per million population). Therefore, the governance challenge is to create a robust, standardized protocol that prevents malpractice without creating insurmountable logistical barriers to organ donation.

The ethical dimensions of brain death certification are profound, touching upon the intersection of medicine, law, and public trust. The primary ethical concern raised in the Supreme Court of India petition is the potential for a conflict of interest, where the rush to harvest organs might compromise the thoroughness of the death declaration process. This highlights the need for a strict separation between the medical team treating the patient and the transplant team, a principle embedded in the Transplantation of Human Organs and Tissues Act, 1994. Furthermore, the petitioner alleges that the lack of verifiable material and potential conflict of interest among medical staff points to a need for more objective testing to ensure public trust. Building public trust is crucial for improving India's deceased organ donation rates, which lag far behind countries like Spain. This requires transparent, standardized, and easily verifiable protocols. The social challenge involves educating the public about the concept of brain stem death—an irreversible condition distinct from a coma—and fostering a culture of voluntary organ donation, shifting reliance away from living relatives who face inherent health risks.